AYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome. After the bullish news, AYTU stock hit the all time low level. 52 Week Range 0.76 - 7.20 LADENBURG THALM has a price target of $14.50 for the stock. I think a reversal is...
I have been looking at this pair since a while, one of my favourites. I see a possible short (fast) trade in here, we touched the trendline and in the same moment, we touched 38% Fibonacci and a 4H resistance, just waiting on this last 2H candle closing in 1 hour. Target at least the last low, from there we could take profit with half position and leave the...
ALTHOUGH PHENOMENAL STUDIES IN UK FROM THEIR PARENT PLC THEY HAVE FINALIZED A SECONDARY THAT HAS LED TO AN INCREASE IN PRICE WHICH IS RARE. IT WAS OVER SUBSCRIBED AND IT WENT QUICK. GWPH IS STUCK IN CHANNEL ON UPTREND AND WILL CONTINUE TO RISE POSSIBLE RESISTANCE IS IT'S 8 APX 88.64 EMA AND 10 APX 87.16 EMA HOWEVER IT HAS SHOWN STRENGTH THROUGH THIS DILUTION AND...